Clinical Study for Cell-cultured Influenza Vaccine

JRCT ID: jRCTs031200112

Registered date:10/09/2020

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: Influenza A(H7N9)
• Date of first enrollment: 10/09/2020
• Target sample size: 70
• Study type: Interventional
• Intervention(s): Vaccine muscle injection (2 times, 3 weeks apart)

Outcome(s)

• Primary Outcome: Antibody titer
• Secondary Outcome: Side Effect and Adverse Reaction

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: Not applicable
• Gender: Both
• Include criteria: Healthy Volunteers
• Exclude criteria: History of influenza A(H7) infection

Related Information

• Primary Sponsor: Sato Morihiko
• Source(s) of Monetary Support: Japan Agency for Medical Research and Development